Kiniksa Pharmaceuticals, Ltd. - (KNSA): Price and Financial Metrics

Kiniksa Pharmaceuticals, Ltd. - (KNSA): $19.28

0.42 (-2.13%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add KNSA to Watchlist
Sign Up

KNSA Price/Volume Stats

Current price $19.28 52-week high $28.15
Prev. close $19.70 52-week low $16.56
Day low $19.17 Volume 243,900
Day high $19.91 Avg. volume 589,621
50-day MA $20.04 Dividend yield N/A
200-day MA $22.05 Market Cap 1.39B

KNSA Stock Price Chart Interactive Chart >


Kiniksa Pharmaceuticals, Ltd. - (KNSA) Company Bio


Kiniksa Pharmaceuticals, Ltd., a clinical-stage biopharmaceutical company, focuses on the discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need worldwide. Its clinical-stage product candidates include Rilonacept, which is in Phase II clinical trials for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; and KPL-716, a monoclonal antibody, which is in Phase 1a/1b clinical trial for the treatment of prurigo nodularis and atopic dermatitis. Kiniksa Pharmaceuticals, Ltd. was founded in 2015 and is based in Hamilton, Bermuda


KNSA Latest News Stream


Event/Time News Detail
Loading, please wait...

KNSA Latest Social Stream


Loading social stream, please wait...

View Full KNSA Social Stream

KNSA Price Returns

1-mo 5.13%
3-mo -9.44%
6-mo -25.85%
1-year -3.07%
3-year 83.10%
5-year 11.25%
YTD -2.53%
2024 12.77%
2023 17.09%
2022 27.27%
2021 -33.39%
2020 59.76%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!